188 related articles for article (PubMed ID: 35864381)
1. ISG15 as a prognostic biomarker in solitary fibrous tumour.
Mondaza-Hernandez JL; Moura DS; Lopez-Alvarez M; Sanchez-Bustos P; Blanco-Alcaina E; Castilla-Ramirez C; Collini P; Merino-Garcia J; Zamora J; Carrillo-Garcia J; Maestro R; Hindi N; Garcia-Foncillas J; Martin-Broto J
Cell Mol Life Sci; 2022 Jul; 79(8):434. PubMed ID: 35864381
[TBL] [Abstract][Full Text] [Related]
2. Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour.
Stacchiotti S; Saponara M; Frapolli R; Tortoreto M; Cominetti D; Provenzano S; Negri T; Dagrada GP; Gronchi A; Colombo C; Vincenzi B; Badalamenti G; Zuco V; Renne SL; Collini P; Morosi C; Dei Tos AP; Bello E; Pilotti S; Casali PG; D'Incalci M; Zaffaroni N
Eur J Cancer; 2017 May; 76():84-92. PubMed ID: 28284173
[TBL] [Abstract][Full Text] [Related]
3. ALDH1 is an immunohistochemical diagnostic marker for solitary fibrous tumours and haemangiopericytomas of the meninges emerging from gene profiling study.
Bouvier C; Bertucci F; Métellus P; Finetti P; Maues de Paula A; Forest F; Mokhtari K; Miquel C; Birnbaum D; Vasiljevic A; Jouvet A; Coindre JM; Loundou A; Figarella-Branger D
Acta Neuropathol Commun; 2013 May; 1():10. PubMed ID: 24252471
[TBL] [Abstract][Full Text] [Related]
4. Expression of p53 as a biomarker of pazopanib efficacy in solitary fibrous tumours: translational analysis of a phase II trial.
Napolitano A; Moura DS; Hindi N; Mondaza-Hernandez JL; Merino-Garcia JA; Ramos R; Dagrada GP; Stacchiotti S; Graziano F; Vincenzi B; Martin-Broto J
Ther Adv Med Oncol; 2022; 14():17588359221116155. PubMed ID: 35965642
[TBL] [Abstract][Full Text] [Related]
5. The prognostic significance of interferon-stimulated gene 15 (ISG15) in invasive breast cancer.
Kariri YA; Alsaleem M; Joseph C; Alsaeed S; Aljohani A; Shiino S; Mohammed OJ; Toss MS; Green AR; Rakha EA
Breast Cancer Res Treat; 2021 Jan; 185(2):293-305. PubMed ID: 33073304
[TBL] [Abstract][Full Text] [Related]
6. ISG15 is downregulated by KLF12 and implicated in maintenance of cancer stem cell-like features in cisplatin-resistant ovarian cancer.
Zhang Q; Wang J; Qiao H; Huyan L; Liu B; Li C; Jiang J; Zhao F; Wang H; Yan J
J Cell Mol Med; 2021 May; 25(9):4395-4407. PubMed ID: 33797839
[TBL] [Abstract][Full Text] [Related]
7. The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer.
Bektas N; Noetzel E; Veeck J; Press MF; Kristiansen G; Naami A; Hartmann A; Dimmler A; Beckmann MW; Knüchel R; Fasching PA; Dahl E
Breast Cancer Res; 2008; 10(4):R58. PubMed ID: 18627608
[TBL] [Abstract][Full Text] [Related]
8. Analyses of prognosis-related factors of intracranial solitary fibrous tumors and hemangiopericytomas help understand the relationship between the two sorts of tumors.
Zeng L; Wang Y; Wang Y; Han L; Niu H; Zhang M; Ke C; Chen J; Lei T
J Neurooncol; 2017 Jan; 131(1):153-161. PubMed ID: 27671018
[TBL] [Abstract][Full Text] [Related]
9. Association between programmed cell death ligand-1 expression and extracranial metastasis in intracranial solitary fibrous tumor/hemangiopericytoma.
Kamamoto D; Ohara K; Kitamura Y; Yoshida K; Kawakami Y; Sasaki H
J Neurooncol; 2018 Sep; 139(2):251-259. PubMed ID: 29675794
[TBL] [Abstract][Full Text] [Related]
10. A GRIA2 and PAX8-positive renal solitary fibrous tumor with NAB2-STAT6 gene fusion.
Ichiyanagi O; Ito H; Takai S; Naito S; Kato T; Nagaoka A; Yamakawa M
Diagn Pathol; 2015 Sep; 10():155. PubMed ID: 26337721
[TBL] [Abstract][Full Text] [Related]
11. Activity of axitinib in progressive advanced solitary fibrous tumour: Results from an exploratory, investigator-driven phase 2 clinical study.
Stacchiotti S; Simeone N; Lo Vullo S; Morosi C; Greco FG; Gronchi A; Barisella M; Collini P; Zaffaroni N; Dagrada GP; Frezza AM; Mariani L; Casali PG
Eur J Cancer; 2019 Jan; 106():225-233. PubMed ID: 30528807
[TBL] [Abstract][Full Text] [Related]
12. Solitary Fibrous Tumour: A Single Institution Retrospective Study and Further Validation of a Prognostic Risk Assessment System.
Friis RB; Safwat A; Baad-Hansen T; Aggerholm-Pedersen N
Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):798-804. PubMed ID: 30206022
[TBL] [Abstract][Full Text] [Related]
13. Interferon-stimulated gene 15 and ISGylation are upregulated in glioblastoma.
Tecalco-Cruz AC; Velasco-Loyden G; Robles-Villarruel L; Cortes-González CC; Zepeda-Cervantes J; Pineda B; Chagoya de Sánchez V
Biochem Biophys Res Commun; 2022 Sep; 621():144-150. PubMed ID: 35834923
[TBL] [Abstract][Full Text] [Related]
14. Expanding the spectrum of malignant progression in solitary fibrous tumors: a study of 8 cases with a discrete anaplastic component--is this dedifferentiated SFT?
Mosquera JM; Fletcher CD
Am J Surg Pathol; 2009 Sep; 33(9):1314-21. PubMed ID: 19718788
[TBL] [Abstract][Full Text] [Related]
15. Extrapleural solitary fibrous tumor: A distinct entity from pleural solitary fibrous tumor. An update on clinical, molecular and diagnostic features.
Ronchi A; Cozzolino I; Zito Marino F; Accardo M; Montella M; Panarese I; Roccuzzo G; Toni G; Franco R; De Chiara A
Ann Diagn Pathol; 2018 Jun; 34():142-150. PubMed ID: 29660566
[TBL] [Abstract][Full Text] [Related]
16. Malignant solitary fibrous tumour of the prostate: four cases emphasising significant histological and immunophenotypical overlap with sarcomatoid carcinoma.
Bakhshwin A; Berry RS; Cox RM; Li R; Reynolds JP; Rubin BP; McKenney JK
Pathology; 2020 Oct; 52(6):643-648. PubMed ID: 32758370
[TBL] [Abstract][Full Text] [Related]
17. ISG15 induces ESRP1 to inhibit lung adenocarcinoma progression.
Qu T; Zhang W; Qi L; Cao L; Liu C; Huang Q; Li G; Li L; Wang Y; Guo Q; Guo Y; Ren D; Gao Y; Wang J; Meng B; Zhang B; Cao W
Cell Death Dis; 2020 Jul; 11(7):511. PubMed ID: 32641707
[TBL] [Abstract][Full Text] [Related]
18. Pathological prognostic markers in central nervous system solitary fibrous tumour/hemangiopericytoma: Evidence from a small series.
Bertero L; Anfossi V; Osella-Abate S; Disanto MG; Mantovani C; Zenga F; Rudà R; Garbossa D; Soffietti R; Ricardi U; Papotti M; Cassoni P
PLoS One; 2018; 13(9):e0203570. PubMed ID: 30183767
[TBL] [Abstract][Full Text] [Related]
19. The many faces of solitary fibrous tumor; diversity of histological features, differential diagnosis and role of molecular studies and surrogate markers in avoiding misdiagnosis and predicting the behavior.
Tariq MU; Din NU; Abdul-Ghafar J; Park YK
Diagn Pathol; 2021 Apr; 16(1):32. PubMed ID: 33879215
[TBL] [Abstract][Full Text] [Related]
20. Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour.
Stacchiotti S; Tortoreto M; Baldi GG; Grignani G; Toss A; Badalamenti G; Cominetti D; Morosi C; Dei Tos AP; Festinese F; Fumagalli E; Provenzano S; Gronchi A; Pennacchioli E; Negri T; Dagrada GP; Spagnuolo RD; Pilotti S; Casali PG; Zaffaroni N
Eur J Cancer; 2014 Nov; 50(17):3021-8. PubMed ID: 25269954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
